Related Experiment Video
Updated: Aug 13, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Intravesical chemotherapy versus immunotherapy for superficial bladder cancer
1Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Seminars in Urologic Oncology
|February 1, 1996
Summary
Choosing intravesical therapy for superficial bladder cancer depends on stage, grade, and history. Selecting the right drug involves balancing benefits against risks, with options like thiotepa, mitomycin, doxorubicin, and bacille Calmette-Guérin (BCG).
Area of Science:
- Urology
- Oncology
- Pharmacology
Background:
- Superficial bladder cancer treatment decisions require careful consideration of disease characteristics and patient history.
- Intravesical therapy is a common treatment modality, necessitating informed agent selection.
Purpose of the Study:
- To review available intravesical therapy agents for superficial bladder cancer.
- To guide clinicians in selecting the most appropriate agent based on efficacy and toxicity profiles.
Main Methods:
- Review of pharmacological properties and clinical applications of thiotepa, mitomycin, doxorubicin, and bacille Calmette-Guérin (BCG).
- Comparison of agent efficacy for different bladder cancer stages and grades.
- Evaluation of systemic absorption and side effect profiles for each agent.
Main Results:
- Thiotepa: effective for low-grade lesions, limited for high-grade tumors/carcinoma in situ, significant myelosuppression due to systemic absorption.
- Mitomycin: effective for first-line and recurrent disease, low systemic absorption and side effects due to high molecular weight.
- Doxorubicin: used more in Europe/Japan, high molecular weight.
- Bacille Calmette-Guérin (BCG): treatment of choice for carcinoma in situ and high-grade T1 lesions, but associated with the highest incidence of adverse reactions.
Conclusions:
- Agent selection for intravesical bladder cancer therapy must weigh potential benefits against risks of complications.
- Mitomycin offers a favorable safety profile compared to thiotepa.
- Bacille Calmette-Guérin (BCG) is highly effective but requires careful management due to toxicity.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...